
MRVL · Nasdaq
Consensus is Buy across 29 analysts, with a mean price target of $250. The supplied consensus reports no low or high target, so the target cluster and dispersion cannot be measured. It also does not identify the most bullish or least bullish analyst, any named firms, or the direction of target and rating revisions during the past week. The substantive disagreement is valuation versus operating prospects: Zacks says AI-driven growth supports Marvell’s premium valuation, while competition and margin pressure raise the case for holding rather than adding. The available evidence therefore supports a positive consensus but not a quantified view of analyst disagreement.